Perkins Capital Management’s LeMaitre Vascular LMAT Stock Holding History

Perkins Capital Management’s Portfolio LMAT Stock Details LMAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.82M	Sell	25,825 -3,075	-11%	-$293K	2.64%	11
2025 Q4	$2.34M	Sell	28,900 -1,561	-5%	-$134K	1.86%	13
2025 Q3	$2.67M	Sell	30,461 -250	-0.8%	-$22.3K	2.35%	12
2025 Q2	$2.55M	Sell	30,711 -1,675	-5%	-$140K	2.56%	11
2025 Q1	$2.72M	Sell	32,386 -250	-0.8%	-$23.3K	2.87%	8
2024 Q4	$3.01M	Sell	32,636 -1,150	-3%	-$111K	2.67%	9
2024 Q3	$3.14M	Sell	33,786 -415	-1%	-$36K	2.94%	9
2024 Q2	$2.81M	Sell	34,201 -1,100	-3%	-$80.8K	2.65%	7
2024 Q1	$2.34M	Hold	35,301	–	–	1.95%	15
2023 Q4	$2M	Sell	35,301 -135	-0.4%	-$7.07K	1.71%	15
2023 Q3	$1.93M	Hold	35,436	–	–	1.91%	14
2023 Q2	$2.38M	Sell	35,436 -1,000	-3%	-$61K	2.08%	14
2023 Q1	$1.88M	Sell	36,436 -1,150	-3%	-$55.8K	1.77%	16
2022 Q4	$1.73M	Sell	37,586 -1,314	-3%	-$61.5K	1.83%	18
2022 Q3	$1.97M	Buy	+38,900	New	+$1.94M	2.21%	13
2022 Q2	–	Sell	-42,000	Closed	-$1.95M	–	112
2022 Q1	$1.95M	Hold	42,000	–	–	1.6%	23
2021 Q4	$2.11M	Sell	42,000 -9,700	-19%	-$502K	1.42%	24
2021 Q3	$2.75M	Sell	51,700 -100	-0.2%	-$5.63K	1.7%	19
2021 Q2	$3.16M	Sell	51,800 -1,950	-4%	-$104K	1.79%	17
2021 Q1	$2.62M	Sell	53,750 -850	-2%	-$39.8K	1.52%	18
2020 Q4	$2.21M	Sell	54,600 -2,100	-4%	-$75.1K	1.45%	24
2020 Q3	$1.84M	Buy	+56,700	New	+$1.7M	1.69%	17
2020 Q1	$1.61M	Buy	64,530 +2,500	+4%	+$77.2K	1.94%	15
2019 Q4	$2.23M	Buy	62,030 +900	+1%	+$31.1K	2%	12
2019 Q3	$2.09M	Hold	61,130	–	–	1.8%	15
2019 Q2	$1.71M	Buy	61,130 +230	+0.4%	+$6.39K	1.2%	27
2019 Q1	$1.89M	Sell	60,900 -3,500	-5%	-$93.4K	1.24%	22
2018 Q4	$1.52M	Hold	64,400	–	–	1.18%	23
2018 Q3	$2.5M	Sell	64,400 -150	-0.2%	-$5.41K	1.5%	16
2018 Q2	$2.16M	Sell	64,550 -1,250	-2%	-$44.5K	1.55%	11
2018 Q1	$2.38M	Sell	65,800 -2,900	-4%	-$100K	2.15%	6
2017 Q4	$2.19M	Sell	68,700 -8,375	-11%	-$287K	2.1%	6
2017 Q3	$2.88M	Sell	77,075 -8,175	-10%	-$278K	3.02%	6
2017 Q2	$2.66M	Sell	85,250 -23,425	-22%	-$676K	2.95%	7
2017 Q1	$2.68M	Buy	+108,675	New	+$2.55M	2.76%	7
2016 Q4	–	Sell	-110,883	Closed	-$2.2M	–	106
2016 Q3	$2.2M	Sell	110,883 -27,475	-20%	-$480K	2.2%	8
2016 Q2	$1.97M	Sell	138,358 -7,540	-5%	-$115K	2.26%	7
2016 Q1	$2.26M	Sell	145,898 -304	-0.2%	-$4.36K	2.83%	5
2015 Q4	$2.52M	Sell	146,202 -22,493	-13%	-$325K	2.71%	5
2015 Q3	$2.06M	Sell	168,695 -12,110	-7%	-$155K	2.29%	6
2015 Q2	$2.18M	Sell	180,805 -4,444	-2%	-$43.7K	1.92%	7
2015 Q1	$1.55M	Sell	185,249 -3,700	-2%	-$29K	1.3%	19
2014 Q4	$1.45M	Sell	188,949 -2,000	-1%	-$14.3K	1.24%	21
2014 Q3	$1.31M	Hold	190,949	–	–	1.11%	26
2014 Q2	$1.58M	Buy	190,949 +30,000	+19%	+$235K	1.11%	29
2014 Q1	$1.3M	Buy	160,949 +4,000	+3%	+$32K	0.91%	37
2013 Q4	$1.26M	Buy	156,949 +76,000	+94%	+$588K	0.85%	42
2013 Q3	$542K	Buy	80,949 +28,141	+53%	+$191K	0.39%	80
2013 Q2	$345K	Buy	+52,808	New	+$333K	0.27%	89

Other funds holding LMAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Perkins Capital Management's LMAT Position: Q1 2026 in Review

Perkins Capital Management reduced its LeMaitre Vascular (LMAT) stake by 11% in Q1 2026, selling an estimated $293K and leaving 25,825 shares worth $2.82M. The position accounts for 2.64% of the portfolio, ranked #11.

Perkins Capital Management first reported a position in LMAT in Q2 2013 and has held it in 49 quarters since. The position peaked at $3.16M in Q2 2021. 339 funds tracked by Wall St. Rank hold LMAT as of Q1 2026.

Perkins Capital Management held 25,825 shares of LeMaitre Vascular worth $2.82M as of Q1 2026.
Perkins Capital Management sold 3,075 LeMaitre Vascular shares in Q1 2026, an estimated $293K.
LeMaitre Vascular made up 2.64% of Perkins Capital Management's portfolio in Q1 2026, its #11 holding.
Perkins Capital Management first reported a position in LeMaitre Vascular in Q2 2013 and has held it in 49 quarters since.
Perkins Capital Management's LeMaitre Vascular position peaked at $3.16M in Q2 2021.
339 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2026.

Based on Perkins Capital Management's 13F filing for Q1 2026, filed 23 Apr 2026.